Evaluation of the anti-inflammatory effect of continous insulin infusion in non-diabetic patients undergoing cardia surgery - ND

• Conditions: Patients candidate to cardiac surgery; MedDRA version: 9.1Level: SOCClassification code 10007541Term: Cardiac disorders

• Registration Number: EUCTR2007-001481-32-IT
• Lead Sponsor: AZIENDA OSPEDALIERA OSPEDALE POLICLINICO CONSORZIALE

Brief Summary

Not available

Detailed Description

Not available

Study Timeline

• Study Start: 2007-03-23
• Last Update Posted: 10 July 2012

Recruitment & Eligibility

• Status: ot Recruiting
• Sex: All
• Target Recruitment: Not specified

Inclusion Criteria

Patients candidate to cardiac surgery
Are the trial subjects under 18? no
Number of subjects for this age range:
F.1.2 Adults (18-64 years) yes
F.1.2.1 Number of subjects for this age range
F.1.3 Elderly (>=65 years) no
F.1.3.1 Number of subjects for this age range

Exclusion Criteria

Diabetes mellitus BMI 30 kg/m2 Age 75 Infections

Study & Design

• Study Type: Interventional clinical trial of medicinal product
• Study Design: Not specified

Primary Outcome Measures

Name	Time	Method
Main Objective: Evaluation of the effect of continous insulin infusion on the PCR, pro-inflammatory cytokines such as tumor necrosis factor-alfa, IL-1, IL-6 ;Secondary Objective: Evaluation of the effect of continous insulin infusion on the infectious complications in patients undergoing cardia surgery;Primary end point(s): PCR, IL-1, IL-6, TNF-alfa levels